Literature DB >> 7575685

The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups.

E Yelin1, L F Callahan.   

Abstract

OBJECTIVE: To provide an indication of the economic, social, and psychological impact of musculoskeletal conditions in the United States.
METHODS: Review of the literature combined with estimates of data concerning health care utilization and acute and chronic disability due to musculoskeletal conditions, from the 1990-1992 National Health Interview Survey.
RESULTS: The cost of musculoskeletal conditions was $149.4 billion in 1992, of which 48% was due to direct medical care costs and the remainder was due to indirect costs resulting from wage losses. This amount translates to approximately 2.5% of the Gross National Product, a sharp rise since the prior studies, even if part of the increase is an artifact of improved accounting methods. Each year, persons with musculoskeletal conditions make 315 million physician visits, have more than 8 million hospital admissions, and experience approximately 1.5 billion days of restricted activity. Approximately 42% of persons with musculoskeletal conditions--more than 17 million in all--are limited in their activities.
CONCLUSION: The economic and social costs of musculoskeletal conditions are substantial. These conditions are responsible for a sizable amount of health care use and disability, and they significantly affect the psychological status of the individuals with the conditions as well as their families.

Entities:  

Mesh:

Year:  1995        PMID: 7575685     DOI: 10.1002/art.1780381002

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  77 in total

Review 1.  Combination therapy for autoimmune diseases: the rheumatoid arthritis model.

Authors:  N Fathy; D E Furst
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Cost-of-illness studies. Useful for health policy?

Authors:  M A Koopmanschap
Journal:  Pharmacoeconomics       Date:  1998-08       Impact factor: 4.981

Review 3.  International variation in hip replacement rates.

Authors:  H Merx; K Dreinhöfer; P Schräder; T Stürmer; W Puhl; K-P Günther; H Brenner
Journal:  Ann Rheum Dis       Date:  2003-03       Impact factor: 19.103

Review 4.  The effects of exercise on human articular cartilage.

Authors:  F Eckstein; M Hudelmaier; R Putz
Journal:  J Anat       Date:  2006-04       Impact factor: 2.610

5.  Synthesis of vibroarthrographic signals in knee osteoarthritis diagnosis training.

Authors:  Chin-Shiuh Shieh; Chin-Dar Tseng; Li-Yun Chang; Wei-Chun Lin; Li-Fu Wu; Hung-Yu Wang; Pei-Ju Chao; Chien-Liang Chiu; Tsair-Fwu Lee
Journal:  BMC Res Notes       Date:  2016-07-19

6.  Prescription Opioid Use and Satisfaction With Care Among Adults With Musculoskeletal Conditions.

Authors:  Brian D Sites; Jordon Harrison; Michael D Herrick; Melissa M Masaracchia; Michael L Beach; Matthew A Davis
Journal:  Ann Fam Med       Date:  2018-01       Impact factor: 5.166

7.  Quantitative MRI of Human Cartilage In Vivo: Relationships with Arthroscopic Indentation Stiffness and Defect Severity.

Authors:  Tuomas Svärd; Martti Lakovaara; Harri Pakarinen; Marianne Haapea; Ilkka Kiviranta; Eveliina Lammentausta; Jukka Jurvelin; Osmo Tervonen; Risto Ojala; Miika Nieminen
Journal:  Cartilage       Date:  2016-12-28       Impact factor: 4.634

8.  The effect of cigarette smoking on musculoskeletal-related disability.

Authors:  Andrew E Lincoln; Gordon S Smith; Paul J Amoroso; Nicole S Bell
Journal:  Am J Ind Med       Date:  2003-04       Impact factor: 2.214

9.  Work correlates of back problems and activity restriction due to musculoskeletal disorders in the Canadian national population health survey (NPHS) 1994-5 data.

Authors:  D C Cole; S A Ibrahim; H S Shannon; F Scott; J Eyles
Journal:  Occup Environ Med       Date:  2001-11       Impact factor: 4.402

10.  Racial differences in analgesic/anti-inflammatory medication use and perceptions of efficacy.

Authors:  Kelli L Dominick; Hayden B Bosworth; Jason B Hsieh; Barry K Moser
Journal:  J Natl Med Assoc       Date:  2004-07       Impact factor: 1.798

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.